Costimulatory mechanisms in the elderly

Vaccine

Volumn 18, Issue 16, 2000, Pages 1661-1665

  Effros, Rita B ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

CD28; T cells; Telomere shortening

Indexed keywords

B7 ANTIGEN; CD28 ANTIGEN;

AGING; ANTIGEN EXPRESSION; GENE EXPRESSION; HUMAN; LYMPHOCYTE PROLIFERATION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION;

EID: 0033977119     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(99)00503-4     Document Type: Article

References (41)

1. Azuma M., Phillips J.H., Lanier L.L. CD28- T lymphocytes: antigenic and functional properties. J. Immunol. 150:1993;1147-1159.
2. Boucher N., Defeu-Duchesne T., Vicaut E., Farge D., Effros R.B., Schachter F. CD28 expression in T cell aging and human longevity. Exp. Geronol. 33:1998;267-282.
3. Effros R.B. Loss of CD28 expression on T lymphocytes: a marker of replicative senescence. Dev. Compar. Immunol. 21:1997;471-478.
4. Schmidt D., Goronzy J.J., Weyand C.M. CD4(+) CD7- CD28- T cells are expanded in rheumatoid arthritis and are characterized by autoreactivity. J. Clin. Invest. 97:1996;2027-2037.
5. Effros R.B., Allsopp R., Chiu C.P., et al. Shortened telomeres in the expanded CD28- CD8+ subset in HIV disease implicate replicative senescence in HIV pathogenesis. AIDS/Fast Track. 10:1996;F17-F22.
6. Posnett D.N., Sinha R., Kabak S., Russo C. Clonal populations of T cells in normal elderly humans: the T cell equivalent to "benign monoclonal gammopathy" J. Exp. Med. 179:1994;609-618.
7. Lewis D.E., Tang D.S.N., Adu-Oppong A., Schober W., Rodgers J.R. Anergy and apoptosis in CD8+ T cells from HIV-infected persons. J. Immunol. 153:1994;412-420.
8. Beverly B., Kang S., Lenardo M., Schwartz R. Reversal of in vitro T cell clonal anergy by IL-2 stimulation. Int. Immunol. 4:1992;661-671.
9. Pawelec G., Effros R.B., Caruso C., Remarque E., Barnett Y., Solana R. T cells and aging (update February 1999). Front Biosci. 4:1999;D216-D269.
10. Campisi J., Dimri G., Hara E. Control of replicative senescence. Schneider J.R. Handbook of the biology of aging. 1996.
11. Smith J.R., Pereira-Smith O.M. Replicative senescence: implications for in vivo aging and tumor suppression. Science. 273:1996;63-66.
12. Morgan D.A., Ruscetti F.W., Gallo R. Selective in vitro growth of T lymphocytes from normal human bone marrows. Science. 193:1976;1007-1008.
13. Breoker BM, Tsygankov AY, Meuller-Fleckenstein I et al., Immortalization of human T cell clones by Herpesvirus saimiri. Signal transduction analysis reveals functional CD3, CD4, and IL-2 receptors, J. Immunol. 151:1184-92.
14. Effros R.B., Pawelec G. Replicative Senescence of T lymphocytes: Does the Hayflick Limit lead to immune exhaustion? Immunology Today. 18:1997;450-454.
15. Adibzadeh M., Pohla H., Rehbein A., Pawelec G. Long-term culture of monoclonal human T lymphocytes: models for immunosenescence? Mech. Ageing Dev. 83:1995;171-183.
16. Levine B.L., Bernstein W.B., Connors M., et al. Effects of CD28 costimulation on long-term proliferation of CD4+ T cells in the absence of exogenous feeder cells. J. Immunol. 159:1997;5921-5930.
17. Grubeck-Loebenstein B., Lechner H., Trieb K. Long term in vitro growth of human T cell clones: can post-mitotic senescent cell populations be defined? Int. Arch. Allergy Immunol. 104:1994;232-239.
18. Harley C., Futcher A.B., Greider C. Telomeres shorten during ageing of human fibroblasts. Nature. 345:1990;458-460.
19. Effros R.B., Boucher N., Porter V., et al. Decline in CD28+ T cells in centenarians and in long-term T cell cultures a possible cause for both in vivo and in vitro immunosenescence. Exp. Gerontol. 29:1994;601-609.
20. Perillo N.L., Naeim F., Walford R.L., Effros R.B. The in vitro senescence of human lymphocytes: failure to divide is not associated with a loss of cytolytic activity or memory T cell phenotype. Mech. Ageing Dev. 67:1993;173-185.
21. June C.H., Bluestone J.A., Nadler L., Thompson C.B. The B7 and CD28 receptor families. Immunology Today. 15:1994;321-331.
22. Shimizu Y., Van Seventer G., Ennis E., Newman W., Horgan K., Shaw S. Crosslinking of the T cell-specific accessory molecules CD7 and CD28 modulates T cell adhesion. J. Exp. Med. 175:1992;577-582.
23. Weng N.P., Palmer L.D., Levine B.L., Lane H.C., June C.H., Hodes R.J. Tales of tails: regulation of telomere length and telomerase activity during lymphocyte development, differentiation, activation, and aging. Immunological Reviews. 160:1997;43-54.
24. Shay J., Wright W. Telomerase activity in human cancer. Current Opinion in Oncology. 8:1996;66-71.
25. Bodnar A.G., Kim N.W., Effros R.B., Chiu C.P. Mechanism of telomerase induction during T cell activation. Exp. Cell Res. 228:1996;58-64.
26. Weng N., Levine B.L., June C.H., Hodes R.J. Regulation of telomerase RNA template expression in human T lymphocyte development and activation. J. Immunol. 158:1997;3215-3220.
27. Vaziri H., Schachter F., Uchida I., et al. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am. J. Hum. Genet. 52:1993;661-667.
28. Valenzuela HFaERB. Loss of telomerase inducibility in memory T cells following multiple encounters with antigen. Submitted 1999.
29. Monteiro J., Batliwalla F., Ostrer H., Gregersen P.K. Shortened telomeres in clonally expanded CD28-CD8+ T cells imply a replicative history that is distinct from their CD28+CD8+ counterparts. J. Immunol. 156:1996;3587-3590.
30. Wolthers K.C., Bea G., Wisman P., et al. T cell telomere length in HIV-1 infection. No evidence for increased CD4+ turnover. Science. 274:1996;1546-1547.
31. Altman J.D., Moss P.A.H., Goulder P.J.R., et al. Phenotypic analysis of antigen-specific T lymphocytes. Science. 274:1996;94-96.
32. Michie C.A., McLean A., Alock C., Beverley P.C.L. Lifespan of human lymphocyte subsets defined by CD45 isoforms. Nature. 360:1992;264-265.
33. McMichael A. Cytotoxic T lymphocytes specific for influenza virus. Curr. Top. Microbiol. Immunol. 189:1994;75-91.
34. Mbawuike I.N., Lange A.R., Couch R.B. Diminished influenza A virus-specific cytotoxic T lymphocyte activity among elderly persons. Viral Immunol. 6:1993;55-64.
35. Alexander R.B., Brady F., Leffell M.S., Tsai V., Celis E. Specific T cell recognition of peptides derived from prostate-specific antigen in patients with prostate cancer. Urology. 51:1998;150-157.
36. Tripp R.A., Hou S., McMickle A., Houston J., Doherty P.C. Recruitment and proliferation of CD8+ T cells in respiratory virus infections. J. Immunol. 154:1995;6013-6021.
37. Tough D., Borrow P., Sprent J. Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science. 272:1996;1947-1950.
38. Miller R. The aging immune system: primer and prospectus. Science. 273:1996;70-74.
39. Rocha B., Dautigny N., Pereira P. Peripheral T lymphocytes: Expansion potential and homeostatic regulation of pool sizes and CD4/CD8 ratios in vivo. Eur. J. Immun. 19:1989;905-911.
40. Bodnar A., Quellette M., Frolkis M., et al. Extension of life-span by introduction of telomerase into normal human cells. Science. 279:1998;349-352.
41. Effros R.B. Replicative senescence in the immune system: impact of the Hayflick Limit on T cell function in the elderly. Am. J. Hum. Gen. 62:1998;1003-1007.